Sort
10,766 grants matching “checkpoint inhibitor”
An integrated translational approach to overcome drug resistance
$2,500,407Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2017 · CA
SPORE in Gastrointestinal Cancers
$2,500,000Alison P Klein · Johns Hopkins University · P50 · FY2018 · CA
Yale SPORE in Skin Cancer
$2,500,000Marcus W Bosenberg · Yale University · P50 · FY2018 · CA
Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
$2,500,000George J Weiner · University Of Iowa · P50 · FY2018 · CA
Targeted Therapies in Melanoma
$2,498,687Meenhard Herlyn · Wistar Institute · P01 · FY2020 · CA
Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 in a Community Oncology Setting
$2,494,906Song Yao · Roswell Park Cancer Institute Corp · UH3 · FY2023 · CA
Fred Hutchinson Cancer Research Center Lung SPORE
$2,491,191A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2019 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,490,943Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2020 · CA
Targeted Therapies in Melanoma
$2,487,446Meenhard Herlyn · Wistar Institute · P01 · FY2021 · CA
THE THERAPY OF AML
$2,483,417Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,483,069Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,482,574Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2019 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,478,520Antoni Ribas · University Of California Los Angeles · P01 · FY2024 · CA
Fred Hutchinson Cancer Center Lung SPORE
$2,471,718A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
Targeting Myeloid Metabolism to Reprogram the Tumor Microenvironment of Glioblastoma
$2,467,799Alexander H. Stegh · Washington University · R01 · FY2025 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,462,161Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Brain Tumor Clinical and Clinical Research Program
$2,458,438Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2018 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,453,778Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2022 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,453,222Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response
$2,452,679Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2023 · CA
Fred Hutchinson Cancer Research Center Lung SPORE
$2,447,085A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2023 · CA
Fred Hutchinson Cancer Research Center Lung SPORE
$2,447,059A. McGarry Houghton · Fred Hutchinson Cancer Center · P50 · FY2022 · CA
Liver Cancer Program
$2,440,951Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
THE THERAPY OF AML
$2,440,745Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA
Mayo Clinic Breast Cancer SPORE
$2,438,534Matthew Philip Goetz · Mayo Clinic Rochester · P50 · FY2017 · CA